TNFRSF12A and gastric adenocarcinoma: Further, K-M curves demonstrated that the progression-free survival (PFS) and overall survival (OS) rates of high TNFRSF12A expression group in STAD were all lower than that of low TNFRSF12A expression group (Figures 1B, C).